መነሻ › Multiple Myeloma › ፍሎሪዳ › Miami
በMiami፣ FL ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Myeloma የሚደረጉ 21 ጥናቶች በMiami እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Miami, Miami
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami Sylvester Comprehensive Cancer Center, Miami
- University of Miami/Sylvester Cancer Institute - Alex's Place, Miami
- University of Miami/Sylvester Cancer Institute - Griffin Cancer Research Building, Miami
- እና 2 ተጨማሪ
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Miami
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
- University of Miami Hospital and Clinics, Miami
- እና 3 ተጨማሪ
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics, Miami
- Sylvester Comprehensive Cancer Center - Kendall, Miami
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Miami
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Miami Don Soffer Clinical Research Center, Miami
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Miami
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Miami, Miami
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
- University of Miami Hospital and Clinics, Miami
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
ተሳታዮችን በመፈለግ ላይ
- University of Miami, Miami
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Miami Hospitals, Miami
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Miami, Miami
- Miami Cancer Institute, Miami
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Miami
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Miami
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Miami Cancer Institute, Miami
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Miami, Miami
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami
በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች
- New York City, NY60 ጥናቶች
- Boston, MA42 ጥናቶች
- Atlanta, GA41 ጥናቶች
- Houston, TX38 ጥናቶች
- Durham, NC37 ጥናቶች
- Nashville, TN32 ጥናቶች
- Denver, CO27 ጥናቶች
- Rochester, MN24 ጥናቶች
- St. Louis, MO24 ጥናቶች
- Columbus, OH24 ጥናቶች
- Baldwin Park, CA23 ጥናቶች
- Chicago, IL22 ጥናቶች
በMiami ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር42 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)36 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር31 ጥናቶች
- የፕሮስቴት ካንሰር27 ጥናቶች
- ከባድ ሰውነት27 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ24 ጥናቶች
- Metastatic Cancer24 ጥናቶች
- የእንቁላል ካንሰር23 ጥናቶች
- ከመጠን በላይ ክብደት23 ጥናቶች
- አልሰራቲቭ ኮላይቲስ21 ጥናቶች
- አልዛይመር በሽታ20 ጥናቶች
- የሳንባ ካንሰር20 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።